693. Over-Expression of miR-145 Enhances the Effectiveness of HSVtk Gene Therapy for Malignant Glioma

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)36497-8
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Elsevier BV

Related search

Gene Therapy for Malignant Glioma

Molecular and Cellular Therapies
2014English

Gene Therapy for Malignant Glioma

Japanese Journal of Neurosurgery
SurgeryNeurology
2003English

A Super Gene Expression System Enhances the Anti-Glioma Effects of Adenovirus-Mediated REIC/Dkk-3 Gene Therapy

Scientific Reports
Multidisciplinary
2016English

Oncolytic Viral Therapy of Malignant Glioma

Neurotherapeutics
NeurologyPharmacology
2009English

Targeting Therapy for Malignant Glioma by Means of Immunoliposomes.

Drug Delivery System
Pharmaceutical Science
1996English

Effective Cytokine Gene Therapy Against an Intracranial Glioma Using a Retrovirally Transduced IL-4 Plus HSVtk Tumor Vaccine

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
1999English

An Overview of Alternating Electric Fields Therapy (NovoTTF Therapy) for the Treatment of Malignant Glioma

Current Neurology and Neuroscience Reports
NeuroscienceNeurology
2016English

Argonaute 2 Drives miR-145-5p-dependent Gene Expression Program in Breast Cancer Cells

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2019English

miR-221/222 Promote Malignant Progression of Glioma Through Activation of the Akt Pathway

International Journal of Oncology
Cancer ResearchOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy